Back to top

Image: Bigstock

MasTec, Orchid Island, Applied Materials, NXP and Amtech highlighted as Zacks Bull and Bear of the Day

Read MoreHide Full Article

For Immediate Release

Chicago, IL – June 11, 2019 – Zacks Equity Research Rogers (ROG - Free Report) as the Bull of the Day, Orchid Island Capital (ORC - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Applied Materials, Inc. (AMAT - Free Report) , NXP Semiconductors N.V. (NXPI - Free Report) and Amtech Systems, Inc. (ASYS - Free Report) .

Here is a synopsis of all five stocks:

Bull of the Day:

With the market running towards highs and in the midst of a strong move off the lows, it feels like everything is going to go up forever. You need to be cautious as that is never the case. While there are plenty of stocks which have moved for the right reasons, there are some duds out there you could be running into. One way to avoid those duds is to lean on the strength of the Zacks Rank. Stocks with solid Zacks Ranks like today’s Bull of the Day have strong earnings trends which help underpin market moves.

Today’s Bull of the Day is Zacks Rank #1 (Strong Buy) Rogers. This company designs, develops, manufactures and sells engineered materials and components for mission critical applications. The Company's segments are Advanced Connectivity Solutions (ACS), Elastomeric Material Solutions (EMS), Power Electronics Solutions (PES) and Other.

The reason for the favorable Zacks Rank lies in the recent moves coming from analysts. Analysts have pushed up their estimates for the current quarter and current year. This bullish sentiment has increased our Zacks Consensus Estimates from $1.42 to $1.55 for the current quarter while current year numbers have gone up from $5.93 to $6.64. That’s the main reason why this stock is currently a Zacks Rank #1 (Strong Buy). Also, the Electronics – Miscellaneous Components industry is in the Top 38% of our Zacks Industry. Strong stock from a strong industry which could lead to strong returns.

Bear of the Day:

Stocks with strong earnings trends tend to outperform the broad market in the long run. The reason is simple, if earnings go up, even if valuation remains the same, the stock price will rise. One way to find stocks with the strongest earnings trends is to lean on the power of the Zacks Rank. Stocks with weakening or negative earnings trends will be on the low end of the rank. Today’s Bear of the Day is one with a weaker earnings trend. That’s why they are a Zacks Rank #5 (Strong Sell).

Today’s Bear of the Day is Orchid Island Capital. Orchid Island is a specialty finance company that invests in residential mortgage-backed securities (RMBS). The Company's business objective is to provide attractive risk-adjusted total returns to its investors over the long term through a combination of capital appreciation and the payment of regular monthly distributions. The Company's portfolio consists of two categories of Agency RMBS: pass-through Agency RMBS and structured Agency RMBS.

The reason for the unfavorable Zacks Rank lies in the series of earnings estimate revisions coming in to the downside. Analysts have dropped their earnings estimates for both the current year and next year over the last ninety days. The bearish sentiment has cut down our Zacks Consensus Estimates for the current year from $1.04 to 95 cents while next year’s number has dropped from $1.07 to $1 even.

3 Semiconductor Stocks to Buy Right Now

Shares of some of the biggest names in the semiconductor industry, including Advanced Micro Devices, Nvidia and Micron had soared in 2019. The comebacks of many chip giants were largely a function of market-wide selloffs that created buying opportunities to start the year.

With that said, AMD stock has continued to climb even as the historically cyclical semiconductor industry faces a near-term downturn. Even industry heavyweights are beholden to their customers’ product cycles, capital investments, and more. On top of that, chip oversupply can hurt pricing power, as is currently the case for some firms.

Still, despite some of the current headwinds, the industry looks poised to remain highly valuable within the larger technological revolution. Semiconductor companies are poised to help drive forward the growth of the Internet of Things, artificial intelligence, autonomous vehicles, and much more. And it won’t just be the likes of Tesla, Apple, Microsoft, Google and Amazon that are set to turn big profits and see their stocks climb as these industries expand.

Therefore, a return to growth is likely on the horizon for the industry as a whole, even if some face rough near-term outlooks. So, let’s take a look at three Zacks buy-ranked semiconductor stocks right now.

1. Applied Materials, Inc.

Shares of Applied Materials have surged over 32% in 2019 to outpace its industry’s 16% average climb. The Semiconductor equipment maker is coming off a better-than-projected second quarter of fiscal 2019. AMAT, like many other chip firms, saw its earnings and revenue slip from the year-ago period. Looking ahead, Applied Materials is projected to see its adjusted fiscal 2019 earnings fall 33% from 2018 on the back of a 16% revenue decline.

However, the company’s 2020 revenues are projected to jump 8.5% above our current-year estimate to help lift earnings 18.3% higher than 2019. Applied Materials has also seen its earnings estimate revision activity trend heavily in the right direction recently, especially for fiscal 2019 and 2020. This positivity, which signals that at least some analysts are more bullish on AMAT’s bottom line, helps the company earn a Zacks Rank #2 (Buy) at the moment. Applied Materials also sports an “A” grade for Value in our Style Scores system and its trading at 12.5X forward 12-month Zacks Consensus EPS estimates. This marks a discount compared its industry’s 17.7X average and its own three-year high of 17.4X. And AMAT is a dividend payer with a yield of 2.02% at the moment.

2. NXP Semiconductors N.V.

NXP Semiconductors provides secure connectivity solutions for embedded applications, which includes connected vehicles and more. Like AMAT, shares of NPXI are up over 30% this year. The company is also coming off an impressive first-quarter fiscal 2019 earnings beat. The firm reported adjusted EPS of $1.95 per share to crush our $1.55 a share estimate. NXP Semiconductors is projected to see it current-quarter earnings soar 41.6% to reach $1.77 per share.

Meanwhile, NXP’s adjusted full-year revenue is expected to climb by 5.4%. Peeking further ahead, the company’s 2020 earnings are projected to surge 18.3% above our current year estimate. Plus, NXPI has earned a ton of positive earnings estimate revisions for both the coming two quarters, as well as fiscal 2019 and 2020. These recent trends help NXP Semiconductors earn a Zacks Rank #2 (Buy). NXPI also sports a “B” grade for Value. The company’s price/sales ratio of 3.3 represents a discount compared to its industry’s 4.4 average. The Eindhoven, Netherlands-based firm also pays a dividend, with a 1.08% yield at the moment.

3. Amtech Systems, Inc.

Amtech manufactures capital equipment from silicon wafer handling automation to thermal processing used in semiconductor devices and fabricating solar cells. Shares of ASYS have climbed roughly 30% in 2019, but still rest firmly below $10 per share, which might deter some investors. But along its ‘cheap’ price tag, Amtech’s price/sales ratio of 0.66 represents a huge discount compared to industry’s 2.2 average.  

The company has received some positive earnings estimate revisions over the last 30 days, with more positivity coming for fiscal 2019 and 2020. On top of that, the company’s consensus earnings estimates have jumped on the back of these revisions. Amtech is currently a Zacks Rank #1 (Strong Buy) that rocks an “A” grade for Momentum and a “B” for Value. Investors should also note that Amtech has crushed its quarterly earnings estimates in the trailing two quarters, by 133% and 50%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Published in